Results 241 to 250 of about 2,312,760 (293)
The Effects of Clazakizumab on Peripheral Blood and Kidney Transcriptomes in Patients With Late Antibody-Mediated Rejection. [PDF]
Kidney Int RepZhang R +9 more
europepmc +1 more source
Development of Non-HLA Antibodies and Their Association With Antibody-Mediated Rejection in Pediatric Kidney Transplant Recipients. [PDF]
Transpl IntSchmidt F +8 more
europepmc +1 more source
Effect of felzartamab on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies. [PDF]
Nat MedDiebold M +12 more
europepmc +1 more source
Antibody-Mediated Rejection of Solid-Organ Allografts [PDF]
New England Journal of Medicine, 2018 To the editor: the comprehensive review article by Loupy and Lefaucheur (Sept. 20 issue)1 on antibody-mediated rejection describes major advances in understanding the pathophysiological process and diagnosis of antibody-mediated rejection, but successful treatment is still limited to the acute forms of antibody-mediated rejection.2 Allograft loss ...
Gary Curhan, Alexandre Loupy
exaly +9 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Opinion in Organ Transplantation, 2015
Pulmonary antibody-mediated rejection (AMR) while contributing to acute and chronic allograft dysfunction remains a diagnostic and therapeutic challenge. The diagnostic tenets upon which AMR is defined will be reviewed in the light of recent studies.The introduction of solid phase assays such as the Luminex platform has provided a wealth of ...
Glen P, Westall +2 more
openaire +4 more sources
Pulmonary antibody-mediated rejection (AMR) while contributing to acute and chronic allograft dysfunction remains a diagnostic and therapeutic challenge. The diagnostic tenets upon which AMR is defined will be reviewed in the light of recent studies.The introduction of solid phase assays such as the Luminex platform has provided a wealth of ...
Glen P, Westall +2 more
openaire +4 more sources
Current Opinion in Organ Transplantation, 2017
The review outlines the diagnosis, clinical implications, and treatment strategies for acute and chronic antibody-mediated rejection (AMR) after orthotopic liver transplantation (OLT).A combination of clinical work-up, histopathology, C4d staining, and donor-specific antibody (DSA) should be used to diagnose AMR.
Rachel, Hogen +2 more
+5 more sources
The review outlines the diagnosis, clinical implications, and treatment strategies for acute and chronic antibody-mediated rejection (AMR) after orthotopic liver transplantation (OLT).A combination of clinical work-up, histopathology, C4d staining, and donor-specific antibody (DSA) should be used to diagnose AMR.
Rachel, Hogen +2 more
+5 more sources
Clinics in Chest Medicine, 2023
Antibody-mediated rejection (AMR) is a form of lung allograft rejection that is emerging as an important risk factor for chronic lung allograft dysfunction and decreased long-term survival. In this review, we provide a brief overview of our current understanding of its pathophysiology with an emphasis on donor-specific antibodies before moving on to ...
Laura P, Halverson, Ramsey R, Hachem
openaire +2 more sources
Antibody-mediated rejection (AMR) is a form of lung allograft rejection that is emerging as an important risk factor for chronic lung allograft dysfunction and decreased long-term survival. In this review, we provide a brief overview of our current understanding of its pathophysiology with an emphasis on donor-specific antibodies before moving on to ...
Laura P, Halverson, Ramsey R, Hachem
openaire +2 more sources
Current Opinion in Organ Transplantation, 2012
The diagnosis of antibody-mediated rejection (AMR) has been revolutionized in recent years by advances in the detection of human leukocyte antigen (HLA) and non-HLA antibodies and by the standardized classification of histologic and immunologic changes in endomyocardial biopsies.
Michelle M, Kittleson +1 more
openaire +2 more sources
The diagnosis of antibody-mediated rejection (AMR) has been revolutionized in recent years by advances in the detection of human leukocyte antigen (HLA) and non-HLA antibodies and by the standardized classification of histologic and immunologic changes in endomyocardial biopsies.
Michelle M, Kittleson +1 more
openaire +2 more sources